LeslieSKeanMD
Pediatric Hematology & Oncology • Boston, MAAssociate Professor, Pediatrics, U of WA Sch of Med
Are you Dr. Kean?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 40 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-355-6000- Is this information wrong?
Summary
- Dr. Leslie Kean, MD is a pediatric hematologist/oncologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts, Washington, and Georgia. She is affiliated with Boston Children's Hospital and Dana-Farber Cancer Institute.
Education & Training
Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2003 - 2005- Emory University School of MedicineResidency, Pediatrics, 1999 - 2003
- Emory University School of MedicineClass of 1999
Certifications & Licensure
MA State Medical License 2018 - 2025
WA State Medical License 2013 - 2020
GA State Medical License 2003 - 2019- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT Start of enrollment: 2009 Nov 01
- Abatacept as GVHD Prophylaxis Phase 2 Start of enrollment: 2013 Feb 01
- Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial) Start of enrollment: 2017 May 01
Publications & Presentations
PubMed
- Major breakthroughs in hematopoietic stem cell transplantation and future challenges in clinical implementation.Leslie S Kean, Bruce R Blazar> ;The Journal of Clinical Investigation. 2024 Apr 15
- Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplan...Anna Sureda, Paul A Carpenter, Andrea Bacigalupo, Vijaya Raj Bhatt, Josu de la Fuente, Aloysius Ho, Leslie Kean, Jong Wook Lee, Isabel Sánchez-Ortega, Bipin N Savani, ...> ;Bone Marrow Transplantation. 2024 Mar 5
- 1 citationsHigher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.Takuto Takahashi, Mahmoud Al-Kofahi, Mutaz Jaber, Brandi Bratrude, Kayla Betz, Yvonne Suessmuth, Alison Yu, Donna S Neuberg, Sung W Choi, Jeffrey Davis, Christine Dunc...> ;Blood. 2023 Aug 24
- Join now to see all
Press Mentions
- Pilot Study Investigates Axicabtagene Ciloleucel in Primary and Secondary CNS LymphomaDecember 13th, 2022
- Tonix Pharmaceuticals Announces Collaboration with Boston Children’s Hospital to Study TNX-1500 (Fc-Modified Anti-CD40L mAb) for the Prevention of Graft-Versus-Host Disease (GvHD) Following Hematopoietic Stem Cell Transplantation in AnimalsDecember 5th, 2022
- From Our Labs and Clinics: 10 Research Advances in 2021December 30th, 2021
- Join now to see all
Grant Support
- Novel Biologic Therapies For BMT: Mechanistic Evaluation In Rhesus MacaquesNational Heart, Lung, And Blood Institute2010–2012
- Adoptive Cellular Therapies To Enhance Tolerance And Protective ImmunityNational Institute Of Allergy And Infectious Diseases2008–2011
- Innate Immunity And Transplantatation ToleranceNational Institute Of Allergy And Infectious Diseases2006–2009
- Innate Immunity And Transplantation ToleranceNational Institute Of Allergy And Infectious Diseases2007
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
Boston Children's HospitalBoston, Massachusetts
